Longitude Prize on Antimicrobial Resistance (AMR)
May 2014 – September 2022
We have a winner!
We are proud to announce that the £8 million Longitude Prize on AMR has been awarded to Sysmex Astrego for the PA-100 AST System. The game-changing solution is a novel point-of-care diagnostic test that rapidly and accurately identifies the presence of a bacterial infection and the right antibiotic to prescribe.
The Longitude Prize on Dementia
September 2022– September 2026
£4,420,000 prize pot
The Longitude Prize on Dementia will be awarded to the creator of a breakthrough technology that learns from a person living with dementia, adapting and compensating for their condition as it progresses, and enabling them to continue living independently for longer.
The Longitude Prize on ALS
Partner with us to run this challenge!
We are currently designing a global Challenge Prize on ALS (amyotrophic lateral sclerosis). ALS is a devastating condition with no cure, affecting 1 in 300 of us. We believe a Challenge Prize can drive developments in ALS treatment and raise awareness of this life-limiting disease.